Nationalizing efavirenz : compulsory licence, collective invention and neo--developmentalism in Brazil - HAL Accéder directement au contenu
Chapitre d'ouvrage Année : 2019

Nationalizing efavirenz : compulsory licence, collective invention and neo--developmentalism in Brazil

Résumé

This chapter examines the legal, technological and industrial trajectory of an antiretroviral drug, efavirenz, which has been distributed free of charge to HIV/Aids patients by the Brazilian Ministry of Health since the early 2000s. In May 2007 a presidential decree suspended the exclusive rights of the patent owner, Merck, to the exploitation of the molecule in Brazil, and authorized the production of a generic version by local laboratories. This compulsory license by the Brazilian state is also intended to perpetuate the policy of universal access to treatment, with a view to combatting the Aids epidemic and boosting the country’s pharmaceutical industry. Nationalization of efavirenz has given rise to experimentation with collective production in the form of an industrial consortium and inaugurated a policy of partnerships between public and private pharmaceutical laboratories.
Fichier principal
Vignette du fichier
chap 2-.pdf ( 272.19 Ko ) Télécharger
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

halshs-03975575, version 1 (06-02-2023)

Identifiants

Citer

Maurice Cassier, Marilena Correa. Nationalizing efavirenz : compulsory licence, collective invention and neo--developmentalism in Brazil. Cassier Maurice, Correa Marilena. Health Innovation and Social Justice in Brazil, Palgrave Macmillan, p 59-90, 2019, 978-3-319-76833-5. ⟨10.1007/978-3-319-76834-2_3⟩. ⟨halshs-03975575⟩
12 Consultations
94 Téléchargements
Dernière date de mise à jour le 27/04/2024
comment ces indicateurs sont-ils produits

Altmetric

Partager

Gmail Facebook Twitter LinkedIn Plus